COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials (CanSino Biologics Inc) (real clinical drug)
real clinical drugSupplier: uk-clinical · SCTID 40712911000001109
Actual medicinal product Generic COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials